D.E. Shaw & Co
XAGE

D.E. Shaw & Co’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

D.E. Shaw & Co’s Portfolio XAGE Stock Details XAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-811
Closed -$251K – 4542
2023
Q2 		$251K Hold
811
– – ﹤0.01% 3665
2023
Q1 		$247K Hold
811
– – ﹤0.01% 3820
2022
Q4 		$241K Hold
811
– – ﹤0.01% 4174
2022
Q3 		$236K Hold
811
– – ﹤0.01% 4404
2022
Q2 		$236K Hold
811
– – ﹤0.01% 4475
2022
Q1 		$237K Hold
811
– – ﹤0.01% 4770
2021
Q4 		$235K Buy
+811
New +$236K ﹤0.01% 4801

Other funds holding XAGE

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CMU
Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's XAGE Position: Q3 2023 in Review

D.E. Shaw & Co sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 811 shares — an estimated $251K sold.

D.E. Shaw & Co first reported a position in XAGE in Q4 2021 and held it in 7 quarters. The position peaked at $251K in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • D.E. Shaw & Co reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 811 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $251K.
  • D.E. Shaw & Co first reported a position in Longevity Health Holdings, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's Longevity Health Holdings, Inc. Common Stock position peaked at $251K in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.